Published Date: 08 Mar 2023
Almost a month has passed with no news of another cancer vaccine breakthrough.
Read Full NewsModelling shows fewer cases and deaths with screening starting at age 45 years.
A phase 3 trial examines whether carfilzomib-lenalidomide-dexamethasone maintenance therapy improves disease control compared with lenalidomide alone in patients with multiple myeloma.
Although many surgeons avoid it, nipple-sparing mastectomy after radiation is a feasible alternative to skin-sparing mastectomy and may help preserve patients’ psychological well-being.
1.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
2.
How cancer misinformation exploits the way we think
3.
A protein with new anticancer activity has been identified
4.
Finding a clue to the origin of treatment-resistant leukemia in kids
5.
Making informed decisions and managing regret after prostate cancer treatment
1.
Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion
2.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
3.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
4.
Cancer Vaccines In India: The Latest Hope In The Fight Against Disease
5.
Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
4.
Thromboprophylaxis In Medical Settings
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation